Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis
Authors
Keywords
Arginase 2, Retina, Optic neuritis, Neurodegeneration, EAE, Retinal ganglion cells
Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-07
DOI
10.1007/s12035-019-01691-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deficient arginase II expression without alteration in arginase I expression attenuated experimental autoimmune encephalomyelitis in mice
- (2018) Mariam Choudry et al. IMMUNOLOGY
- Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
- (2018) Anna T. Wilmes et al. Journal of Neuroinflammation
- Arginase: A Multifaceted Enzyme Important in Health and Disease
- (2018) R. William Caldwell et al. PHYSIOLOGICAL REVIEWS
- Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis
- (2018) Brienne A. McKenzie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis
- (2018) Massimo Dal Monte et al. Nutrients
- Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responses
- (2018) Abdelrahman Y. Fouda et al. Cell Death & Disease
- Retinal Neuroprotection From Optic Nerve Trauma by Deletion of Arginase 2
- (2018) Zhimin Xu et al. Frontiers in Neuroscience
- Sequential phases of RGC axonal and somatic injury in EAE mice examined using DTI and OCT
- (2018) Christopher Nishioka et al. Multiple Sclerosis and Related Disorders
- Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis
- (2017) Katja Thomas et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
- (2017) Katharina Birkner et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synaptophysin Is a Reliable Marker for Axonal Damage
- (2017) Viktoria Gudi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis
- (2017) Yuriko Azuchi et al. NEUROSCIENCE LETTERS
- Central Administration of 5Z-7-Oxozeaenol Protects Experimental Autoimmune Encephalomyelitis Mice by Inhibiting Microglia Activation
- (2017) Lingli Lu et al. Frontiers in Pharmacology
- CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis
- (2016) Jianhong Bao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis
- (2016) Amena W. Smith et al. JOURNAL OF NEUROCHEMISTRY
- Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury
- (2016) Esraa Shosha et al. Cell Death & Disease
- Retinal Macroglial Responses in Health and Disease
- (2016) Rosa de Hoz et al. Biomed Research International
- IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23
- (2015) Heather M. Grifka-Walk et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
- (2015) Laila M. Poisson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oral disease-modifying therapies for relapsing-remitting multiple sclerosis
- (2014) R. H. Thomas et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Vision and vision-related outcome measures in multiple sclerosis
- (2014) L. J. Balcer et al. BRAIN
- Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study
- (2014) Paolo Giannetti et al. NEUROBIOLOGY OF DISEASE
- Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism
- (2014) S P Narayanan et al. Cell Death & Disease
- Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS
- (2013) Shawn Elms et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina
- (2013) Allen R. Rodriguez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model
- (2013) Lioba Horstmann et al. Journal of Neuroinflammation
- NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS
- (2013) Venu Talla et al. MOLECULAR THERAPY
- Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis
- (2013) Wan-fu Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Arginase as a mediator of diabetic retinopathy
- (2013) Chintan Patel Frontiers in Immunology
- Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis
- (2012) Roberta Brambilla et al. Journal of Neuroinflammation
- Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis
- (2012) Srdjan Ljubisavljevic et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Ganglion Cell Loss in Relation to Visual Disability in Multiple Sclerosis
- (2012) Scott D. Walter et al. OPHTHALMOLOGY
- Saccadic Eye Movement Characteristics in Adult Niemann-Pick Type C Disease: Relationships with Disease Severity and Brain Structural Measures
- (2012) Larry A. Abel et al. PLoS One
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vision in Multiple Sclerosis
- (2011) Reiko E. Sakai et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Oxidative stress and reduced glutamine synthetase activity in the absence of inflammation in the cortex of mice with experimental allergic encephalomyelitis
- (2011) A. Castegna et al. NEUROSCIENCE
- Arginase 2 Deletion Reduces Neuro-Glial Injury and Improves Retinal Function in a Model of Retinopathy of Prematurity
- (2011) Subhadra P. Narayanan et al. PLoS One
- Optic Neuritis and Retinal Ganglion Cell Loss in a Chronic Murine Model of Multiple Sclerosis
- (2011) Thomas A. Quinn et al. Frontiers in Neurology
- Activated Microglia Mediate Axoglial Disruption That Contributes to Axonal Injury in Multiple Sclerosis
- (2010) Owain W. Howell et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis
- (2009) N. Nath et al. JOURNAL OF IMMUNOLOGY
- Activation of Calpain and Caspase Pathways in Demyelination and Neurodegeneration in Animal Model of Multiple Sclerosis
- (2008) Arabinda Das et al. CNS & Neurological Disorders-Drug Targets
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started